Parkman Healthcare Partners LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1777015 STAMFORD, CT

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,261,950

-$35,961 QoQ

Shares Held

380,354

+0.1% QoQ

Ownership

0.430%

of shares outstanding

% of Portfolio

1.07%

of 13F equity value

Holder Rank

#54

of 224 holders

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. MLYS ranks #22 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MBX	MBX Biosciences, Inc.	800,173	$44,169,549
2	PTCT	Ptc Therapeutics, Inc.	435,691	$35,539,314
3	RCUS	Arcus Biosciences, Inc.	919,266	$28,340,970
4	GPCR	Structure Therapeutics Inc.	485,661	$26,065,425
5	VRDN	Viridian Therapeutics, Inc.\DE	1,377,576	$25,306,071
6	AGIO	Agios Pharmaceuticals, Inc.	669,046	$24,828,297
7	INBX	Inhibrx Biosciences, Inc.	256,950	$24,346,012
8	XENE	Xenon Pharmaceuticals Inc.	397,379	$23,985,796

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,261,950	380,354	+0.1%	Shares	Sole	2026-08-14
2026-03-31	$10,297,911	380,137	-7.3%	Shares	Sole	2026-05-15
2025-12-31	$14,887,936	410,249	-9.9%	Shares	Sole	2026-02-17
2025-09-30	$17,273,432	455,523	-1.7%	Shares	Sole	2025-11-14
2025-06-30	$6,272,521	463,601	+57.7%	Shares	Sole	2025-08-14
2025-03-31	$4,667,576	293,928	+2421.3%	Shares	Sole	2025-05-15
2023-06-30	$198,768	11,658	+16.6%	Shares	Sole	2023-08-11
2023-03-31	$156,600	10,000	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.